Clinical Trial Update: A Study to Evaluate ABY-035 in Subjects With Moderate-to-severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ABY-035 in subjects with moderate-to-severe plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ABY-035 (ABY-035)

Snippet

Sponsor: Affibody | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED